Navigation Links
Sedationless Colonoscopy Option May Increase Colorectal Cancer Screening Compliance
Date:10/1/2013

NEW YORK and KISSING, Germany, Oct. 1, 2013 /PRNewswire/ -- invendo medical, manufacturer and distributor of a single-use and computer-assisted ("robotic") colonoscopy system, today announced the results of a survey examining key barriers that impact colorectal cancer screening compliance.  Screening has been shown to decrease colorectal cancer rates in the United States, but according to the American Cancer Society, only about half of people aged 50 or older, for whom screening is recommended, report having undergone colorectal cancer testing consistent with current guidelines.[i]

(Logo: http://photos.prnewswire.com/prnh/20130311/NY73775LOGO

The new survey found that 94% of referring physicians said they were concerned about patients not complying with their colonoscopy recommendation. The top two objections to colonoscopy screening that physicians reported hearing from their patients were concerns about pain (69%) and concerns about sedation (53%). Other indirectly sedation-related reasons not to undergo colonoscopy were people being too busy to take time off work (41%) or not having someone to accompany the patients (38%).

The advantages of invendoscopy™ strongly appealed to the surveyed physicians as 92% of them would be interested in recommending a colonoscopy option that may not require sedation, while 93% would be interested in recommending a colonoscopy option that is performed with a single-use product.

"The key objections to screening identified in this survey are addressed by the invendoscopy system," said John J. Cifarelli, EVP Global Markets of invendo medical.  "As we continue to roll out the invendoscopy system at two renowned New York-based hospitals and prepare to add another hospital on the East Coast, these survey results confirm that there is a clear need for a single-use colonoscope that might enable screening to be done without sedation. In a 2009 clinical study, sedation was required in less than 5% of all cases performed with invendoscopy.[ii]  By providing a gentler colonoscopy option, we can address sedation-related barriers to compliance and ensure patients are appropriately screened for colorectal cancer."

The survey was conducted by Guidepoint Global, an independent research firm, among 100 internal medicine and primary care physicians treating patients in New York City or Providence who regularly refer patients for screening colonoscopy.

About the invendoscopy™ system

The invendoscope™ SC20 has several features new to the field of colonoscopy:

  • it is a single-use colonoscope with a working channel
  • it is not pushed or pulled, but uses a computer-assisted ("robotic") gentle drive technology
  • all endoscopic functions are performed using a handheld device and
  • it reduces forces on the colon wall

About invendo medical - www.invendo-medical.com
Based in New York, U.S.A. and Kissing (near Munich), Germany, invendo medical is a leading developer of disposable endoscopy products in the field of gastroenterology that are hygienically safe and employ "robotic" computer-assisted, gentle advancement technology.

[i] American Cancer Society. Colorectal Cancer Facts & Figures. Available at http://www.cancer.org/research/cancerfactsstatistics/colorectal-cancer-facts-figures. Last accessed September 30, 2013.

[ii] Groth S, Rex DK, Rosch T, Hoepffner N. High Cecal Intubation Rates With a New Computer-Assisted Colonoscope: A Feasibility Study. Am J Gastroenterol. 2011 June; 106(6): 1075–1080.


'/>"/>
SOURCE invendo medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. invendo medical Announces US Market Entry Following Special 510(k) Clearance By FDA For Computer-Assisted Single-Use Colonoscopy System
2. New Study Shows Full Spectrum Endoscopy Procedure Reduces The Miss Rate of Adenomas During Colonoscopy
3. CHPA Applauds Alabamas Adoption Of HB 363
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Biomedical Advanced Research and Development Authority (BARDA) Exercises Option with Pfenex Inc. To Extend Contract for the Development of a Recombinant Protective Antigen (rPA) Based Anthrax Vaccine
6. Seventeen Banner Health facilities achieve final stage of electronic medical record adoption
7. CHPA Applauds Arizonas Adoption Of HB 2263
8. Arena Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
9. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
10. Anoto Digital Pen and Paper Facilitating Adoption of Meaningful Use Certified Electronic Health Record Technology
11. New Options In Knee Replacement Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...   Pulmatrix, Inc ., (NASDAQ: PULM ... announced today that it was added to the Russell ... comprehensive set of U.S. and global equity indexes on ... milestone for Pulmatrix," said Chief Executive Officer Robert ... progress in developing drugs for crucial unmet medical needs, ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
Breaking Medicine News(10 mins):